Protein Kinase CK2 in Human Diseases
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1870-1886
Author(s):
Barbara Guerra and Olaf-Georg Issinger
The Molecular Bases of the Self-Renewal and Differentiation of Leukemic Stem Cells
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
178-187
Author(s):
Kazuhito Naka, Masako Ohmura, Takayuki Hoshii, Teruyuki Muraguchi and Atsushi Hirao
Role of mTOR in Hematological Malignancies
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
211-218
Author(s):
Uzma Athar and Ajeet Gajra
The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
227-234
Author(s):
Arun Rajan and Ajeet Gajra
Wnt Signaling in Development, Disease and Translational Medicine
Journal:
Current Drug Targets
Volume:
9
Page:
513-531
Author(s):
Gary S. Coombs, Tracy M. Covey and David M. Virshup
HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
488-496
Author(s):
Christian Widakowich, Phuong Dinh, Evandro de Azambuja, Ahmad Awada and Martine Piccart-Gebhart
Hyperthermia Associated Osteonecrosis in Young Patients with Pelvic Malignancies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
571-575
Author(s):
Marcus Jager, Stefan Balzer, Rudiger Wessalowski, J. Schaper, Ulrich Gobel, Xinning Li and Rudiger Krauspe
NBS1 Heterozygosity and Cancer Risk
Journal:
Current Genomics
Volume:
9
Page:
275-281
Author(s):
Alessandra di Masi and Antonio Antoccia
DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
417-425
Author(s):
Mark R. Kelley and Melissa L. Fishel
The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
172-179
Author(s):
M. D. Bacolod, S. M. Lin, S. P. Johnson, N. S. Bullock, M. Colvin, D. D. Bigner and H. S. Friedman